In PTCs and CFs, tranilast not only decreased TGF-β1-induced CCN2 mRNA and phosphorylation of Smad2, but also inhibited CCN2-induced ECM protein and cellular hypertrophy [88]. This evidence concerns the gene CCN2 and myalgic encephalomeyelitis/chronic fatigue syndrome.